Federica Miglietta, Oncology Fellow at University of Padova, shared a post by Evandro de Azambuja, Breast Cancer specialist at Jules Bordet, on X: .
“Truly stimulating discussion by P.A. Fasching in the first Mini Oral Session at ESMOBreast24:
- the GOOD: drivers of efficacy
- the BAD: mechanisms of resistance
- the UGLY: toxicity”
Quoting Evandro de Azambuja’s post:
“Mini oral session at ESMOBreast24!”
Source: Federica Miglietta/X and Evandro de Azambuja/X